The following is reproduced from the website of the

University of Missouri-Columbia College of Veterinary Medicine

Canine Genetic Diseases Network

Researchers at the University of Missouri-Columbia College of Veterinary Medicine and collaborators at several colleges and institutions throughout the country and the world are searching for genetic mutations that cause disease and suffering in dogs.

Neuronal Canine Ceroid Lipofuscinosis

The neuronal ceroid-lipofuscinoses (NCLs) are a class of inherited neurological disorders that have been diagnosed in dogs, humans, cats, sheep, goats, cynomolgus monkeys, cattle, horses, and lovebirds. Among dogs, NCL has been reported in many breeds, including English Setters, Tibetan Terriers, American Bulldogs, Dachshunds, Polish Lowland Sheepdogs, Border Collies, Dalmatians, Miniature Schnauzers, Australian Shepherds, Australian Cattle Dogs, Golden Retrievers, and other breeds (see list below). NCL is almost always inherited as an autosomal recessive trait. In humans, mutations in one of at least six different genes can lead to NCL. Mutations in several other genes have been found to be responsible for NCL in one or more animal species.

All of the NCLs have two things in common: pathological degenerative changes occur in the central nervous system, and nerve cells accumulate material that is fluorescent when examined under blue or ultraviolet light. Although neurological signs are always present in canine NCL, these signs vary substantially between breeds and can overlap with signs present in other neurological disorders. Until the gene defect responsible for NCL has been identified for a particular breed, a definitive diagnosis can only be made upon microscopic examination of nervous tissues at necropsy.

The goal of the Columbia College of Veterinary Medicine is to identify the mutation responsible for NCL in each breed where NCL occurs so that the disease can be diagnosed and carriers can be identified on the basis of a DNA-based test. To achieve this goal, we will first need to identify dogs from each breed in which NCL has been definitively diagnosed based on presently available criteria. The first step in identifying potentially affected dogs is for the owner or veterinarian to recognize signs that may be indicative of NCL and bring these dogs to our attention. Toward this end, we list below the signs of NCL that have been reported in the literature or observed in dogs we have examined in our clinics for each breed. Care should be used in relying only on the listed disease signs as these may be based on very few cases and incomplete information. In addition, more than one form of NCL can exist within a particular breed, as appears to be the case among Dachshunds.

Some progress has been made toward the above-stated goal. A mutation in CLN8 is responsible for NCL in English Setters (Katz et al 2005); a mutation in CLN5 is responsible for NCL in Border Collies (Melville et al 2005); and a mutation in CTSD is responsible for NCL in American Bulldogs (Awano et al, 2006). In addition, we recently discovered the mutation for a form of NCL in Longhaired Dachshunds (Awano et al., submitted for publication, 2006). The clinical onset of this Dachshund NCL is much earlier than the Dachshund NCL described in 1980 by Vandevelde and Fatzer, and the ultrastructural appearance of the storage bodies is different, indicating that the Dachshund NCL we studied is a distinct disease. We will publicize the identity of the mutant Dachshund gene as soon as a report of this discovery is accepted for publication in the scientific literature. DNA tests to identify affected, non-symptomatic carriers, and normal dogs are available for these breeds (see below). We are interested in samples from possible affected dogs in the other breeds listed below, or dogs of any breed suspected to have NCL.

 

Description of NCL Symptoms and Clinical Changes in American Bulldogs:

A collaboration of scientists from the Veterinary Neurological Center in Los Vegas, the University of Missouri-Columbia (UMC), the University of California-San Diego, and Cornell University in Ithaca has recently described a new form of NCL in American Bulldogs. At UMC we have been studying DNA from affected American Bulldogs and their relatives, and have discovered the mutation causing NCL in this breed. A DNA test is now available which will definitively identify clear, carrier, and affected dogs. Instructions and forms for sending samples are found in the SAMPLE SUBMISSION section.
 

NCL Description for American Bulldogs

Age of onset of clinical signs: 0.9 to 3 years

Age of death or euthanasia: 3.5 to 5.5 years

Abnormalities often observed by the owner:
Mental changes: Physical symptoms may appear to worsen during times of stress. Affected dogs do not indicate they are in any pain as coordination decreases.
Changes in gait and posture: Initially, uncoordinated movement in the rear is noted. As the disease progresses, affected dogs develop a wide-based stance starting in rear, and eventually involving all four legs. Affected dogs may exhibit muscle twitching, especially when sleeping. The dogs remain well-muscled through the course of the disease.
Visual abnormalities: None reported
Seizures/convulsions: None reported
Other changes: None reported

Abnormalities observed upon clinical examinations:
Clinical neurologic changes: Progressive ataxia and hypermetria is present in all four limbs, but more pronounced in the pelvic limbs. Conscious proprioception and hopping reactions are delayed in the pelvic limbs but normal in the forelimbs on initial examination. In advanced stages conscious proprioception reactions are absent in all four limbs and dogs have difficulty rising from a recumbent position without assistance. A wide-based stance of the pelvic limbs is observed in younger affected dogs; this progresses to a wide-based stance of all four limbs at later examinations. Spinal reflexes and cranial nerve examinations are normal. The dogs remain well muscled.
Clinical ophthalmic changes: None reported
Visual abnormalities: None reported
Retinal changes: None reported
Electroretinography (ERG): None reported
Other clinical findings: None reported


Histopathology
Brain: The entire external surface of the brain has a light brown hue but there is no evidence of cortical atrophy. Microscopically, PAS-positive storage material is present in cerebral cortex, brainstem, and cerebellum. The storage material in all cells exhibits a golden-yellow autofluorescence. Axonal spheroids are present in the brain and spinal cord. Ultrastructurally, storage bodies consist of membrane-bound organelles with cross-sectional diameters generally ranging from 0.5 to 3 microns. The inclusion body profiles are sometimes round but more often irregular. The bulk of the storage body contents are coarsely granular and most storage bodies contain numbers of somewhat spherical aggregates of the granular material. In addition, storage bodies from all 3 cell types contain well-delineated spherical dark-staining inclusions that are mostly smaller than 0.1 microns in diameter. In some cells in and near the Purkinje cell layer of the cerebellum, the perinuclear cytoplasm is filled with storage material that appears to be an aggregation of smaller storage bodies that have fused.
Eyes: Microscopically, PAS-positive storage material is present in ganglion cells of the retina. Under electron microscopic examination, the storage bodies in retinal ganglion cells have an additional ultrastructural feature of lighter-staining spherical inclusions with the relatively uniform electron density typical of lipid droplets.
Other organs and structures: None noted

Mode of inheritance: Autosomal recessive.

Gene containing mutation: The causative mutation has been identified and a DNA test is now available. See details above.

References:
Evans J, Katz ML, Levesque D, Shelton D, deLahunta A and O’Brien DP: A Variant Form of Neuronal Ceroid Lipofuscinosis in American Bulldogs (2005) J. Vet. Internal Med., 19:44-51.

Please visit these websites:

 University of Missouri-Columbia College of Veterinary Medicine and Canine Genetic Diseases Network